首页 >
法规速递
-
国家药品监督管理局 公安部 国家禁毒委员会办公室关于进一步加强普瑞巴林等药品管理的通告（2026年第11号）-2026/4/20
2026-04-21查看详情 > -
Document: Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)-2026/6/2
2026-06-02查看详情 > -
Scientific guideline: ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms - Step 2b-2023/02/07
2023-02-07查看详情 > -
国家药监局 海关总署关于增设泰州市泰州港口岸为药品进口口岸的公告（2023年第110号）-2023/8/31
2023-09-01查看详情 > -
Draft Guidance for Industry: E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports-2024/3/13
2024-03-15查看详情 > -
国家药监局药审中心关于发布《生物制品注册受理审查指南（试行）》的通告（2025年第15号）-2025/2/9
2025-02-10查看详情 > -
Document: Agenda of the HMPC meeting 17-19 March 2025-2025/3/13
2025-03-14查看详情 > -
Document: Procedural advice on paediatric applications-2025/4/15
2025-04-16查看详情 > -
Page: Scientific and technical recommendations: Veterinary Medicines Regulation-2025/5/28
2025-05-29查看详情 > -
Document: QRD guidance on the use of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised (DCP), subsequent recognition (SRP) and national proce
2025-07-02查看详情 >
